BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32664669)

  • 1. The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease.
    Iqbal UH; Zeng E; Pasinetti GM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-pathogen infections and Alzheimer's disease.
    Vigasova D; Nemergut M; Liskova B; Damborsky J
    Microb Cell Fact; 2021 Jan; 20(1):25. PubMed ID: 33509204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.
    Fülöp T; Munawara U; Larbi A; Desroches M; Rodrigues S; Catanzaro M; Guidolin A; Khalil A; Bernier F; Barron AE; Hirokawa K; Beauregard PB; Dumoulin D; Bellenger JP; Witkowski JM; Frost E
    CNS Drugs; 2020 Jul; 34(7):673-695. PubMed ID: 32458360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    Harris SA; Harris EA
    J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of antimicrobial peptides in the early onset of Alzheimer's disease.
    Welling MM; Nabuurs RJ; van der Weerd L
    Alzheimers Dement; 2015 Jan; 11(1):51-7. PubMed ID: 24637300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity.
    Vojtechova I; Machacek T; Kristofikova Z; Stuchlik A; Petrasek T
    PLoS Pathog; 2022 Nov; 18(11):e1010929. PubMed ID: 36395147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.
    Gosztyla ML; Brothers HM; Robinson SR
    J Alzheimers Dis; 2018; 62(4):1495-1506. PubMed ID: 29504537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.
    Devanand DP
    Curr Neurol Neurosci Rep; 2018 Jul; 18(9):55. PubMed ID: 30008124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease.
    Kumar DK; Choi SH; Washicosky KJ; Eimer WA; Tucker S; Ghofrani J; Lefkowitz A; McColl G; Goldstein LE; Tanzi RE; Moir RD
    Sci Transl Med; 2016 May; 8(340):340ra72. PubMed ID: 27225182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.
    Eimer WA; Vijaya Kumar DK; Navalpur Shanmugam NK; Rodriguez AS; Mitchell T; Washicosky KJ; György B; Breakefield XO; Tanzi RE; Moir RD
    Neuron; 2018 Jul; 99(1):56-63.e3. PubMed ID: 30001512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides.
    Li F; Hearn M; Bennett LE
    Crit Rev Microbiol; 2021 Mar; 47(2):240-253. PubMed ID: 33555958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
    Rao CV; Asch AS; Carr DJJ; Yamada HY
    Aging Cell; 2020 Mar; 19(3):e13109. PubMed ID: 31981470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.